XYL.NYSEXylem INC

Form 4: Xylem Director Sells Shares Under 10b5-1 Plan

Sentiment:

Director Share Transaction


Xylem Inc. Director Victoria D. Harker sold 1,800 shares of common stock for approximately $143.63 per share under a pre-arranged trading plan.

Summary

  • Victoria D. Harker, a Director of Xylem Inc., sold 1,800 shares of Xylem common stock.
  • The transaction occurred on August 4, 2025.
  • The shares were sold at a weighted average price of $143.6343 per share, with prices ranging from $143.63 to $143.65.
  • Following this transaction, Ms. Harker directly owns 18,575 shares of Xylem Inc. common stock.
  • The sale was conducted pursuant to a Rule 10b5-1(c) pre-arranged trading plan.

Sentiment

Score: 5

Explanation: The sale of shares by a director, while reducing their direct stake, was conducted under a pre-arranged Rule 10b5-1 trading plan, which suggests the transaction was scheduled in advance and not based on immediate, non-public information. This makes the event largely neutral in terms of immediate sentiment.

Positives

  • The sale was executed under a Rule 10b5-1(c) plan, indicating it was pre-scheduled and not based on new, non-public information.

Negatives

  • A director's sale of shares, even if pre-planned, reduces their direct ownership stake in the company.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

  • Shareholders: A minor reduction in director ownership, but the 10b5-1 plan suggests no new negative implications.

Key Dates

DateDescription
08/04/2025Transaction Date for the sale of common stock.
08/05/2025Filing Date of the Form 4 statement.

Recommendation

hold

This Form 4 filing reports a routine, pre-scheduled sale of a relatively small number of shares by a director under a Rule 10b5-1 plan. Such transactions are typically not indicative of new material information or a change in the company's fundamental outlook. Therefore, it does not provide a basis for a strong buy or sell recommendation, and a "hold" stance is appropriate as this specific filing does not alter the investment thesis.

Keywords

Xylem Inc., XYL, Victoria D. Harker, Director, Share Sale, Insider Trading, Form 4, SEC Filing, 10b5-1 Plan, Common Stock

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.